Monitor Free T4, Not TSH, in Central Hypothyroidism
In patients with central hypothyroidism on levothyroxine (Synthroid), you must monitor free T4 levels—TSH is unreliable and should not be used for dose titration. This is because the pituitary dysfunction that causes central hypothyroidism means TSH cannot accurately reflect thyroid hormone status.
Why TSH Monitoring Fails in Central Hypothyroidism
The fundamental problem is that TSH can remain within the normal range even when patients are hypothyroid in central (secondary/tertiary) hypothyroidism 1. The pituitary gland's impaired ability to produce TSH means this hormone loses its utility as a feedback marker. Multiple guidelines explicitly state that TSH-based monitoring applies only to primary (thyroidal) hypothyroidism 2, 3.
The Correct Monitoring Approach
Target free T4 levels in the upper half of the normal reference range 4, 3. This recommendation is based on:
The FDA label for Synthroid explicitly states: "In patients with secondary (pituitary) or tertiary (hypothalamic) hypothyroidism, the levothyroxine sodium dose should be titrated until the patient is clinically euthyroid and the serum free-T4 level is restored to the upper half of the normal range" 3
Research demonstrates that patients with central hypothyroidism require higher free T4 levels (mean 1.31 ng/dL) compared to euthyroid controls (1.10 ng/dL) to achieve adequate replacement 5
The 2012 AACE/ATA guidelines confirm: "assessment of free T4, not TSH should guide therapy" in central hypothyroidism 4
Practical Monitoring Protocol
Check free T4 levels:
- Every 6-8 weeks during dose titration 4, 3
- Draw blood before the patient takes their daily levothyroxine dose
- Once stable, monitor every 6-12 months 3
Dose adjustments:
- Start with estimated 1.6 mcg/kg/day (or lower in elderly/cardiac patients) 4, 3
- Adjust in 12.5-25 mcg increments based on free T4 results
- Wait 4-6 weeks between adjustments for levothyroxine's long half-life to reach steady state 3
Critical Safety Consideration
Before initiating or increasing levothyroxine in central hypothyroidism, you must rule out or treat concurrent adrenal insufficiency 1. Central hypothyroidism often coexists with other pituitary hormone deficiencies. Starting thyroid hormone replacement when cortisol is deficient can precipitate adrenal crisis by increasing cortisol metabolism. The 2021 ASCO guidelines explicitly state: "If there is uncertainty about whether primary or central hypothyroidism is present, hydrocortisone should be given before thyroid hormone is initiated" 1.
Common Pitfalls to Avoid
- Don't use TSH to guide therapy—it will mislead you in central hypothyroidism
- Don't aim for mid-range free T4—target the upper half of normal
- Don't forget to assess other pituitary axes, particularly the hypothalamic-pituitary-adrenal axis 6
- Don't check labs too frequently—allow 6-8 weeks for steady state after dose changes
The distinction between primary and central hypothyroidism fundamentally changes your monitoring strategy. While TSH works beautifully for primary hypothyroidism, it becomes a useless parameter in central disease, making free T4 your essential guide 3, 7.